2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Translational Drug Development: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors Decoy20, Tislelizumab - Solid Tumor, Adult, HCC - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Active not recruiting | Indaptus Therapeutics, Inc | 120 | 2023-02-28 | 2026-01-13 |
| SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) SurVaxM - Newly Diagnosed Glioblastoma | Phase 2 | Unknown | MimiVax, LLC | 247 | 2021-11-18 | 2024-02-26 |
| NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC NAP (Naptumomab estafenatox), Docetaxel, Obinutuzumab - Non-small Cell Lung Cancer | Phase 2 | Completed | NeoTX Therapeutics Ltd. | 38 | 2021-10-26 | 2025-03-03 |
| Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Nab paclitaxel, Gemcitabine, Dociparstat - Metastatic Pancreatic Cancer | Phase 2 | Terminated | Jazz Pharmaceuticals | 60 | 2011-11-01 | 2022-06-06 |
| A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer Drug will be recommended based on IHC/Fish, CGH and Pan-XenoBank - Previously Treated Metastatic Pancreatic Cancer | Phase 2 | Completed | Translational Drug Development | 35 | 2010-09-01 | 2012-07-17 |
Carcinoma, Non-Small-Cell Lung (2) · Pancreatic Neoplasms (2) · Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Neoplasm Metastasis (1)
Albumin-Bound Paclitaxel (1) · Comparative Genomic Hybridization (1) · Docetaxel (1) · Gemcitabine (1) · N-desulfated,2-O,3-O-desulfated heparin (1) · Taxes (1) · naptumomab estafenatox (1) · obinutuzumab (1) · tislelizumab (1)
United States (5)
Ilana Lorber, MD (1) · Manmeet S Ahluwalia, MD, MBA (1) · Michael Ciesielski, PhD (1) · Mitesh J Borad, MD (1) · Ramesh Ramanathan, MD (1) · Robert Fenstermaker, MD (1) · Stephen Marcus, MD (1)
PMID 10318881, PMID 10623795, PMID 10725753, PMID 10766164, PMID 11221872, PMID 12070671, PMID 12135582, PMID 15758009, PMID 16582593, PMID 16731740, PMID 16918305, PMID 18056471, PMID 20231676, PMID 20422411, PMID 27576783, PMID 29540489, PMID 29921698, PMID 9422522, PMID 9858522